Royalty Pharma Reports Second Quarter 2024 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Wall St set for muted open as tech stocks take a breather
- Oil slips on rise in Middle East crude exports and G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
| REPROS THERAPEUTICS (NASDAQ: RPRX) | Delayed: 56.68 -0.48 (0.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $57.16 | 52 Week High | $3.48 | |||
| Open | $57.10 | 52 Week Low | $0.80 | |||
| Day High | $57.25 | P/E | N/A | |||
| Day Low | $56.68 | EPS | $-1.54 | |||
| Volume | 231,002 | |||||
